Table 3 Most common adverse events following the Common Terminology Criteria for Adverse Events (CTCAE 3.0)
Grades | Neurotoxicity | Alopecia | Asthenia | Thrombocytopenia | Anaemia | Neutropenia | Oral Mucositis | Hepatotoxicity |
|---|---|---|---|---|---|---|---|---|
1 | 17 (18.5%) | 13 (14.1%) | 36 (39.1%) | 5 (5.4%) | 17 (18.5%) | 4 (4.3%) | 10 (10.9%) | 15 (16.3%) |
2 | 18 (19.6%) | 11 (12%) | 37 (40.2%) | 2 (2.2%) | 6 (6.5%) | 6 (6.5%) | 3 (3.3%) | 2 (2.2%) |
3 | 7 (7.6%) | – | 9 (9.8%) | 1 (1.1%) | 0 | 9 (9.8%) | 1 (1.1%) | 2 (2.2%) |
4 | 0 | – | 0 | 0 | 0 | 10 (10.9%) a | 0 | 0 |